Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...

Three-dimensional (3D) cancer models have emerged as pivotal tools in oncology research, offering a more accurate representation of tumor biology compared ...

From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...

AbbVie ABBV has built a substantial oncology franchise. Initially anchored by blood cancer drugs Imbruvica and Venclexta, the company has also been expanding its offerings into solid tumors. Its ...

The Food and Drug Administration (FDA) has added more medicines for cancer, diabetes, high cholesterol, hypertension, and mental illness in its list of drugs exempted from value-added tax (VAT).

U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth up to $25 billion.

Community oncology faces significant challenges from the Inflation Reduction Act's (IRA) drug pricing changes, risking financial stability and patient access to care.

Cancer Drugs Cost More Than Ever. They Often Don’t Extend Lives By Robert Langreth Tanaz Meghjani Rachael Dottle May 28, 2025 ...

The U.S. Food and Drug Administration this week granted permission for the use of a new cancer drug from China despite high-profile strains in ties between the two countries. Akeso said on Friday ...

FILE - The injectable drug Ozempic is shown, July 1, 2023, in Houston. Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will ...

The Biden administration unveiled the next 15 drugs that will undergo Medicare negotiations Friday, just a few days before President-elect Donald Trump takes office. Ozempic and Wegovy, Novo Nordisk’s ...